FDA Warns Consumers about Counterfeit Alli : RushPRNews - Newswire & Global Press Release Distribution

 
Bookmark and Share

FDA Warns Consumers about Counterfeit Alli

January 19, 2010

Washington, DC (RPRN) 01/19/10 — The counterfeit products contain controlled substance sibutramine

The U.S. Food and Drug Administration is today warning consumers about a counterfeit and potentially harmful version of Alli 60 mg capsules (120 count refill kit).

Preliminary laboratory tests conducted by GlaxoSmithKline (GSK)—the maker of the FDA approved over-the-counter weight-loss product— revealed that the counterfeit version did not contain orlistat, the active ingredient in its product. Instead, the counterfeit product contained the controlled substance sibutramine. Sibutramine is a drug that should not be used in certain patient populations or without physician oversight. Sibutramine can also interact in a harmful way with other medications the consumer may be taking.

Consumers began reporting suspected counterfeit Alli to GSK in early December 2009. GSK has determined that the counterfeit product has been sold over the internet. However, there is no evidence at this time that the counterfeit Alli product has been sold through other channels, such as retail stores.

The counterfeit Alli product looks similar to the authentic product, with a few notable differences. The counterfeit Alli has:

Outer cardboard packaging missing a “Lot” code;

Expiration date that includes the month, day, and year (e.g., 06162010); authentic Alli expiration date includes only the month and year (e.g.,: 05/12);

Packaging in a plastic bottle that has a slightly taller and wider cap with coarser ribbing than the genuine product;

Plain foil inner safety seal under the plastic cap without any printed words; the authentic product seal is printed with “SEALED for YOUR PROTECTION”;

Contains larger capsules with a white powder, instead of small white pellets.

Consumers who believe they have received counterfeit Alli are asked to contact the FDA's Office of Criminal Investigations (OCI) by calling 800-551-3989 or by visiting the OCI Web site (http://www.fda.gov/OCI).

Health care professionals and consumers are encouraged to report adverse events that may be related to the use of these counterfeit products to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, or by mail at: MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787.

 

Media Web Address: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm197857.htm
About the author:

FDA is an agency within the Department of Health and Human Services and consists of seven centers and offices

Click here to see all news from this author/company

Filed Under: FDA- Pharmaceutical news, Health and Fitness, Lifestyle, PRESS RELEASE

RUSH PR NEWS newswire and press release services at rushprnews.com / Anne Howard annehowardpublicist.com

Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.

Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.

Rush PR News is not the contact for material published.

RSSFeed PRESS & SOCIAL MEDIA RELEASES

Neurobiologix Launches Methylation Complete Sublingual Enhanced Formula

Austin, TX 07/28/15 · Sublingual Formula Now Includes Additional Bioactive B12 For...

DEA ANNOUNCES 10th NATIONAL PRESCRIPTION DRUG TAKE-BACK

Washington, DC 07/28/15 · DEA Acting Administrator Chuck Rosenberg today announced that...

Publish your press release to 100 digital business news site for $59

New York, NY 07/20/15 · Your press release to be featured on at...

Recombinetics and Newborn Foundation Launch 
Newborn Health Research Institute

SAINT PAUL, MN 07/17/15 · Recombinetics and Newborn Foundation Launch 
Newborn Health Research...

InCycle Becomes Azure Gold Partner

SEATTLE, WA 07/13/15 · InCycle Software, today announced it has achieved a...

Ultraseal's new R-FL-Duplex+ machine sparks interest in casting impregnation

Dusseldorf, Germany 07/08/15 · Ultraseal International attracted great interest in its R-FL-Duplex+...

Dropout announces new website for 2015

London, UK 07/08/15 · The Dropout team are proud to announce the...

Coalition Joins National Coalition for Infant Health

Washington, D.C. 06/25/15 · Newborn Foundation News: Newborn Health leaders convene in DC...

RushPRnews now offers digital news sites +Targeted News outlet Broadcast

SAN FRANCISCO/MONTREAL 06/22/15 · Your press release to be featured on at...

Save our Skies Santa Cruz Launches Petition Urging FAA to Stop the Jet Noise

Santa Cruz, California 06/21/15 · Outraged Citizens fight FAA's NextGenprogram to reclaim quality...